Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...
April 4 (Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday granted emergency-use authorization to Inflarx NV's (IF0G.F), opens new tab monoclonal antibody for the treatment of ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
A one-time shot with an experimental drug halved COVID-19 patients' risk of being hospitalized with the illness compared with a placebo, a late-stage trial shows. However, the treatment may still be ...
Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...
The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND, Ohio (KFOR/Storyful) – Desperate ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Overall, 22 of 37 participants reported improved ...
(RTTNews) - Foster City, California-based Gilead Sciences, Inc. is recalling one lot of Veklury (remdesivir) for Injection 100 mg/vial for treating COVID-19, to the consumer level, due to the presence ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results